Cancer News and Research

Latest Cancer News and Research

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Segasist Technologies launches crowd funding campaign to bring Reconcillio software on cloud

Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio on cloud.

22 Aug 2012

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.

22 Aug 2012

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

The incidence is about 1-3% of all breast cancers. The incidence seems to be increasing due to women delaying their childbearing to when they are in their thirties.

22 Aug 2012

Radiation therapy alone no longer the best choice for early follicular lymphoma

A University of Rochester Medical Center study published in the Journal of Clinical Oncology, challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis.

22 Aug 2012

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development.

22 Aug 2012

Reactions to Rep. Akin's comments: 'Offensive and ignorant;' 'loathsome;' 'bad science'

Opinions are uniformly negative in response to the Senate candidate's comments on rape during a TV interview.

22 Aug 2012

Brand-name drug makers bet coupons will help their products edge out generic competition

If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know. They've begun offering U.S. patients coupons to reduce copayments on brand-name medicines and compete with new generic versions of the drugs.

22 Aug 2012

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

I consider myself to be a fortunate person. I have a good education, a great job and excellent health insurance. I am a baby boomer who has aged reasonably well and can look forward to a fairly comfortable retirement. I am also fortunate because I was diagnosed with hepatitis C by a proactive and knowledgeable doctor in the late 1990s and had the opportunity to be treated and cured. The odds are that if I had not been diagnosed and treated, I would be on a liver transplant list right now, have liver cancer or even be dead from this disease.

22 Aug 2012

Mof protein plays a key role in epigenetics of stem cells

How do stem cells preserve their ability to become any type of cell in the body? And how do they "decide" to give up that magical state and start specializing? If researchers could answer these questions, our ability to harness stem cells to treat disease could explode. Now, a University of Michigan Medical School team has published a key discovery that could help that goal become reality.

22 Aug 2012

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Oxygen Biotherapeutics, Inc., announced today that recent research conducted by its partner, Aurum Biosciences, Glasgow, Scotland, has shown that Oxycyte, OBI's proprietary perfluorocarbon-based intravenous emulsion, improves imaging of the penumbra following acute ischemic stroke in a rat model.

22 Aug 2012

Corporate power presents a major threat to public health

Professor Gerard Hastings from the Institute for Social Marketing at the University of Stirling argues that marketing by multinational corporations "threatens our mental wellbeing, exacerbates inequalities, and encourages unsustainable consumption."

22 Aug 2012

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions.

22 Aug 2012

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition has signed an agreement with the Biobank of CHU UCL Mont-Godinne, an academic hospital in Yvoir, Belgium.

22 Aug 2012

Chemists develop new lab test to examine how DNA damage disrupts protein synthesis

Transcription is a cellular process by which genetic information from DNA is copied to messenger RNA for protein production. But anticancer drugs and environmental chemicals can sometimes interrupt this flow of genetic information by causing modifications in DNA.

22 Aug 2012

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

Investigators at Nationwide Children's Hospital may have discovered a biological explanation for why low levels of oxygen advance spinal muscular atrophy (SMA) symptoms and why breathing treatments help SMA patients live longer. The findings appear in Human Molecular Genetics.

22 Aug 2012

Study highlights Nek9 protein as decisive factor in cell division

A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell division, a fundamental process for both the development of an organism and tissue maintenance.

22 Aug 2012

Roundup: Texas insurance regulator pulls out-of-network notice rules; Bay-Area Komen fundraising suffers after flap; Mass.'s Steward pushing to buy Maine hospital

Texas' top insurance regulator has rescinded new rules designed to help consumers avoid a common pitfall when they seek medical treatment -- big bills for out-of-network care -- a move that angers consumer advocates and doctors groups. The rules were meant to give more than 4 million Texans covered by preferred provider organization health plans, or PPOs, more information about whether they'd pay the higher out-of-network costs if they were hospitalized and seen by a specialist.

22 Aug 2012

GWCI announces new collaboration with National Institutes of Health Federal Credit Union

The National Institutes of Health Federal Credit Union, one of the largest credit unions in the Washington, D.C. metropolitan area and the nation's largest serving the healthcare and biomedical industries has proudly announced a new collaboration with the George Washington Cancer Institute (GWCI).

21 Aug 2012

Declining circumcision rates in the US raise healthcare costs and disease risk

A team of disease experts and health economists at Johns Hopkins warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

21 Aug 2012

Cancer News and Research

Latest Cancer News and Research

FDA warns consumers about potential health risks of two natural dietary supplements

Segasist Technologies launches crowd funding campaign to bring Reconcillio software on cloud

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

Radiation therapy alone no longer the best choice for early follicular lymphoma

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Reactions to Rep. Akin's comments: 'Offensive and ignorant;' 'loathsome;' 'bad science'

Brand-name drug makers bet coupons will help their products edge out generic competition

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

Mof protein plays a key role in epigenetics of stem cells

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Corporate power presents a major threat to public health

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

Chemists develop new lab test to examine how DNA damage disrupts protein synthesis

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

Study highlights Nek9 protein as decisive factor in cell division

Roundup: Texas insurance regulator pulls out-of-network notice rules; Bay-Area Komen fundraising suffers after flap; Mass.'s Steward pushing to buy Maine hospital

GWCI announces new collaboration with National Institutes of Health Federal Credit Union

Declining circumcision rates in the US raise healthcare costs and disease risk

Understanding the DNA Damage Response in Innate Immunity eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Newsletters you may be interested in